Compounded GLP-1 medications use the same active pharmaceutical ingredients as brand names, prepared under pharmaceutical-grade standards
This is followed by preclinical studies to assess pharmacology and toxicity, along with formulation development to enhance oral bioavailability through absorption-enhancement systems
Recommend beginning supplementation, as there is no interaction with the medications
Some patients may be completely asymptomatic, while others might go into full-blown liver failure
All these results, although preliminary, encourage carrying out larger randomized controlled clinical trials
GLP-1 is a naturally occurring incretin hormone, and GLP-1 receptor agonists are a well-defined medication class with multiple approved drugs